In addition, SLC7A11, a cystine/glutamate antiporter that specifically uptakes cystine, was overexpressed in patients with KRAS-mutated lung adenocarcinoma and positively associated with tumor progression. The gene discussed is SLC7A11; the disease is lung adenocarcinoma.